{"id":"W4281654053","doi":"10.3390/curroncol29060328","title":"Refractory Splenic Marginal Zone Lymphoma Responsive to Combination Venetoclax and Bortezomib (Velcade) (V2) Therapy","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Bortezomib; Medicine; Splenic marginal zone lymphoma; Lymphoma; Refractory (planetary science); Multiple myeloma; Lenalidomide; Oncology; Internal medicine; Leukemia; Chronic lymphocytic leukemia; Spleen; Splenectomy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002791545,0.0003834257,0.0005201445,0.0004440224,0.0005394822,0.00055932,0.0003499613,0.0008293624,0.0007853733],"category_scores_gemma":[0.0007891072,0.0001329326,0.0003239463,0.0002871266,0.0003988648,0.0002835312,0.0003078889,0.0007881453,0.0002377826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005228173,"about_ca_system_score_gemma":0.0003437736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00107746,"about_ca_topic_score_gemma":0.001611352,"domain_scores_codex":[0.9998416,0.00003329813,0.00001466715,0.00003353991,0.0000232817,0.00005362888],"domain_scores_gemma":[0.9996246,0.0001534104,0.00004591819,0.00004012519,0.00001903244,0.0001169312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.001168035,0.0002053471,0.02379657,0.0002122378,0.00008555438,0.8915071,0.000399316,0.002167506,0.05132999,0.0009591291,0.001344823,0.02682431],"study_design_scores_gemma":[0.0003906398,0.001749992,0.03617644,0.0000389376,0.0001244995,0.9282188,0.0002055213,0.007293375,0.02087594,0.0007477301,0.004142849,0.00003523272],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989511,0.001713757,0.002049832,0.0008438258,0.00004197251,0.00008644415,0.0001431875,0.0001260364,0.005484045],"genre_scores_gemma":[0.9983274,0.0002923903,0.0005325227,0.000230701,0.0000518602,0.00001112966,0.00009918022,0.000007542732,0.0004471953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00107746,"threshold_uncertainty_score":0.003793359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07733332209479953,"score_gpt":0.3864639387577372,"score_spread":0.3091306166629377,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}